Actorius Innovations And Research
Pune, India· Est.
Indian biotech delivering low‑volume liquid biopsy and CTC‑removal solutions for early cancer detection.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Indian biotech delivering low‑volume liquid biopsy and CTC‑removal solutions for early cancer detection.
Oncology
Technology Platform
Proprietary immunomagnetic capture and microfluidic filtration of circulating tumor cells enabling low‑volume, high‑sensitivity liquid biopsy and CTC removal.
Opportunities
Expanding affordable liquid‑biopsy testing in emerging markets and validating CTC‑removal therapy could unlock new revenue streams and strategic partnerships.
Risk Factors
Regulatory hurdles, competition from established liquid‑biopsy companies, and the need for robust clinical evidence for CTC removal efficacy.
Competitive Landscape
Competes with Guardant Health, GRAIL, and other CTC‑based diagnostics; differentiates through low‑volume blood draw, cost‑effectiveness, and a combined therapeutic removal approach.